Anthony Petrone
Stock Analyst at Mizuho Securities
(4.57)
# 970
Out of 4,676 analysts
659
Total ratings
54.3%
Success rate
9.2%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIVN LivaNova | Maintained: Buy | n/a | $79.41 | - | 29 | Aug 21, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 64.02 → CHF 68.02 | CHF 58.72 | +15.84% | 25 | Aug 13, 2026 | |
| HAE Haemonetics | Maintained: Buy | $90 → $95 | $108.32 | -12.30% | 71 | Aug 11, 2026 | |
| RMD ResMed | Maintained: Buy | $220 → $235 | $236.59 | -0.67% | 32 | Aug 11, 2026 | |
| PLSE Pulse Biosciences | Maintained: Buy | $30 → $45 | $49.00 | -8.16% | 6 | Aug 10, 2026 | |
| DXCM DexCom | Maintained: Buy | $95 | $89.16 | +6.55% | 14 | Aug 4, 2026 | |
| INSP Inspire Medical Systems | Maintained: Buy | $55 → $65 | $61.07 | +6.44% | 20 | Aug 4, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $70 → $60 | $49.86 | +20.34% | 25 | Jul 31, 2026 | |
| AXGN Axogen | Maintained: Buy | $55 → $58 | $49.93 | +16.16% | 4 | Jul 31, 2026 | |
| GKOS Glaukos | Maintained: Buy | $160 → $185 | $181.39 | +1.99% | 27 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $85 | $73.91 | +15.00% | 21 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $115 | $100.87 | +14.01% | 37 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $14.16 | +55.37% | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.38 | +242.86% | 1 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $105 | $90.87 | +15.55% | 30 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $525 → $400 | $371.84 | +7.57% | 18 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $140 → $145 | $140.18 | +3.44% | 23 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $20 | $21.58 | -7.32% | 8 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $9.72 | +74.90% | 34 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $9.52 | +89.08% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $105 | $72.15 | +45.53% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $85 | $73.04 | +16.37% | 39 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $100 | $91.14 | +9.72% | 28 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $18.92 | +10.99% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $27 | $23.18 | +16.48% | 31 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $4.16 | +68.27% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $5 | $5.03 | -0.60% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $4.34 | +84.33% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $125 → $115 | $116.13 | -0.97% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $68.73 | +45.50% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $164.92 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175 | $100.24 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $78.97 | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $0.6928 | n/a | 3 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 | $71.45 | n/a | 7 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $16.79 | n/a | 1 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.3553 | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $18 | $18.50 | n/a | 8 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.0001 | n/a | 5 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.2661 | n/a | 7 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | - | n/a | 4 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $204.07 | n/a | 1 | Aug 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $97 | $14.48 | n/a | 1 | Aug 2, 2016 |
LivaNova
Aug 21, 2026
Maintained: Buy
Price Target: n/a
Current: $79.41
Upside: -
Alcon Inc.
Aug 13, 2026
Maintained: Buy
Price Target: CHF 64.02 → CHF 68.02
Current: CHF 58.72
Upside: +15.84%
Haemonetics
Aug 11, 2026
Maintained: Buy
Price Target: $90 → $95
Current: $108.32
Upside: -12.30%
ResMed
Aug 11, 2026
Maintained: Buy
Price Target: $220 → $235
Current: $236.59
Upside: -0.67%
Pulse Biosciences
Aug 10, 2026
Maintained: Buy
Price Target: $30 → $45
Current: $49.00
Upside: -8.16%
DexCom
Aug 4, 2026
Maintained: Buy
Price Target: $95
Current: $89.16
Upside: +6.55%
Inspire Medical Systems
Aug 4, 2026
Maintained: Buy
Price Target: $55 → $65
Current: $61.07
Upside: +6.44%
Boston Scientific
Jul 31, 2026
Maintained: Buy
Price Target: $70 → $60
Current: $49.86
Upside: +20.34%
Axogen
Jul 31, 2026
Maintained: Buy
Price Target: $55 → $58
Current: $49.93
Upside: +16.16%
Glaukos
Jul 31, 2026
Maintained: Buy
Price Target: $160 → $185
Current: $181.39
Upside: +1.99%
Jul 31, 2026
Maintained: Buy
Price Target: $80 → $85
Current: $73.91
Upside: +15.00%
Jul 29, 2026
Maintained: Buy
Price Target: $120 → $115
Current: $100.87
Upside: +14.01%
Jul 28, 2026
Maintained: Buy
Price Target: $22
Current: $14.16
Upside: +55.37%
Jul 17, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $4.38
Upside: +242.86%
Jul 15, 2026
Maintained: Buy
Price Target: $100 → $105
Current: $90.87
Upside: +15.55%
Jul 15, 2026
Maintained: Hold
Price Target: $525 → $400
Current: $371.84
Upside: +7.57%
Jul 15, 2026
Maintained: Hold
Price Target: $140 → $145
Current: $140.18
Upside: +3.44%
Jul 15, 2026
Maintained: Hold
Price Target: $24 → $20
Current: $21.58
Upside: -7.32%
Jul 15, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $9.72
Upside: +74.90%
Jul 15, 2026
Maintained: Buy
Price Target: $20 → $18
Current: $9.52
Upside: +89.08%
Jul 15, 2026
Maintained: Buy
Price Target: $100 → $105
Current: $72.15
Upside: +45.53%
Jun 3, 2026
Maintained: Buy
Price Target: $100 → $85
Current: $73.04
Upside: +16.37%
Jun 3, 2026
Maintained: Buy
Price Target: $120 → $100
Current: $91.14
Upside: +9.72%
Jun 3, 2026
Maintained: Buy
Price Target: $21
Current: $18.92
Upside: +10.99%
May 14, 2026
Maintained: Hold
Price Target: $22 → $27
Current: $23.18
Upside: +16.48%
May 7, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $4.16
Upside: +68.27%
May 6, 2026
Maintained: Hold
Price Target: $12 → $5
Current: $5.03
Upside: -0.60%
Apr 30, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $4.34
Upside: +84.33%
Apr 20, 2026
Maintained: Hold
Price Target: $125 → $115
Current: $116.13
Upside: -0.97%
Apr 13, 2026
Maintained: Buy
Price Target: $100
Current: $68.73
Upside: +45.50%
Jun 13, 2025
Maintained: Buy
Price Target: $65
Current: $164.92
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $175
Current: $100.24
Upside: n/a
Sep 16, 2021
Rated: Buy
Price Target: $70
Current: $78.97
Upside: n/a
Aug 11, 2021
Rated: Buy
Price Target: $20
Current: $0.6928
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $45
Current: $71.45
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $86
Current: $16.79
Upside: n/a
Sep 17, 2020
Initiated Coverage: Buy
Price Target: $15
Current: $0.3553
Upside: n/a
Aug 13, 2020
Maintained: Hold
Price Target: $25 → $18
Current: $18.50
Upside: n/a
Dec 3, 2019
Maintained: Buy
Price Target: $7
Current: $0.0001
Upside: n/a
Aug 17, 2018
Reiterated: Buy
Price Target: $7 → $6
Current: $0.2661
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: $80 → $95
Current: -
Upside: n/a
Aug 25, 2017
Maintained: Buy
Price Target: $93
Current: $204.07
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $97
Current: $14.48
Upside: n/a